Clinical Trial

Two Schemes Response in Multiple Myeloma

Recruiting
View on ClinicalTrials.gov →
Summary
Retrospective study based on medical records of patients with multiple myeloma, eligible for stem cell transplantation, who received, first-line, the VTD or TD combination.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-02-26.
Trial Details
NCT Number NCT06284395
Lead Sponsor Hospital General de Mexico
Conditions Response, Acute Phase, Survivorship
Enrollment 83 participants
Start Date 2023-11-20
Primary Completion 2024-03-20 (estimated)
Study Completion 2024-10-30 (estimated)
Updated on ClinicalTrials.gov 2024-10-02